Crescita Reports Third Quarter 2022 Results

09.11.2022 - Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the third quarter ended September 30, 2022 ...

Related Keywords

Canada ,Ukraine ,Canadian ,Serge Verreault ,International Financial Reporting Standards ,Bloom Burton Healthcare Lending ,Company Consolidated Audited Financial ,Limitations Of Summary Financial Results Press ,Crescita Therapeutics Inc ,Bloom Burton Healthcare Lending Trust ,Health Canada ,Services Manufacturing ,Cantabria Labs Inc ,Art Filler Universal ,Art Filler Fine Lines ,Art Filler Contour ,Obagi Medical ,Commercial Skincare ,Cantabria Labs ,Middle East ,North Africa ,Canada Emergency Wage Subsidy ,Concerning Limitations ,Summary Financial Results Press ,Consolidated Audited Financial Statements ,Annual Information Form ,